Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol-Reference-Cited by-同舟云学术

Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol

Published:2002-11 Issue:11 Volume:89 Page:1345-1346
ISSN:0007-1323
Container-title:British Journal of Surgery
language:en
Short-container-title:

Author:

Launois B¹²,Maddern G²

Affiliation:

1. Department of Surgery, University of Rennes, 35000 Rennes, France

2. Department of Surgery, The Queen Elizabeth Hospital, Woodville Road, Woodville, South Australia 5011, Australia

Publisher

Oxford University Press (OUP)

Subject

Surgery

Link

http://academic.oup.com/bjs/article-pdf/89/11/1345/36725815/bjs374.pdf

Reference10 articles.

1. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis;Belghiti;Ann Surg,1991

2. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients;Bismuth;Ann Surg,1993

3. Intra-arterial iodine 131-labeled Lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study;Partensky;Arch Surg,2000

4. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group;Muto;N Engl J Med,1996

5. Preoperative treatment of hepatocellular carcinoma (HCC) with radioactive Lipiodol;Raoul;Program/Proceedings American Society of Clinical Oncology,1999

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver;British Journal of Surgery;2003-09-22